These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17087244)

  • 1. [Standardization of coagulologic technique for antithrombin III estimation and its clinical application].
    Berkovskiĭ AL; Sergeeva EV; Kartoshkina AV; Suvorov AV
    Klin Lab Diagn; 2006 Aug; (8):29-30. PubMed ID: 17087244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional assay of plasma antithrombin using polyethylene glycol (PEG) defibrinated plasma.
    Li A; Taylor FB; Chang AK; Peer GT; Dong F; Hinshaw LB
    Thromb Res; 1995 Aug; 79(4):395-403. PubMed ID: 7482443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoenzyme method of determination of antithrombin III].
    Markova OA; Kalashnikov VV; Khvatov VB
    Vopr Med Khim; 1989; 35(5):127-30. PubMed ID: 2694600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.
    Fareed J; Messmore HL; Walenga JM; Bermes EW; Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):288-301. PubMed ID: 6817417
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation testing with the Du Pont aca discrete clinical analyzer.
    Pierson-Perry JF; Wehrly JA; Siefring GE
    Semin Thromb Hemost; 1983 Oct; 9(4):321-33. PubMed ID: 6658463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin-III assay without influence of heparin cofactor II.
    Enomoto M; Tanimizu I; Sakuragawa N
    Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
    Rodzynek JJ; Urbain D; Leautaud P; Wettendorff P; Delcourt A
    Gut; 1984 Oct; 25(10):1050-6. PubMed ID: 6479679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved clinical assay for antithrombin III (heparin cofactor).
    Chockley M; Penner JA
    Am J Clin Pathol; 1980 Aug; 74(2):213-7. PubMed ID: 7405901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis.
    Hoffmann JN; Mühlbayer D; Jochum M; Inthorn D
    Crit Care Med; 2004 Sep; 32(9):1851-9. PubMed ID: 15343012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of activity of antithrombin III - heparin in blood].
    Katsadze IuL; Kotovshchikova MA
    Lab Delo; 1982; (4):232-4. PubMed ID: 6177911
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional and antigenic antithrombin III values in plasma and serum from 115 regular blood donors and antithrombin III in prediction of postoperative thrombosis.
    Nilsen DW; Jeremic M; Weisert OK; Fønstelien E; Godal HC
    Thromb Haemost; 1983 Aug; 50(2):530-3. PubMed ID: 6415845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia.
    Asakura H; Saito M; Ito K; Jokaji Y; Uotani C; Kumabashiri I; Matsuda T
    Thromb Res; 1988 Jun; 50(6):895-9. PubMed ID: 3166241
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The thrombin-antithrombin III complex ELISA test in diagnosis of surgery-induced blood coagulation activation].
    Kemen M; Sperling H; Mumme A; Zumtobel V
    Infusionstherapie; 1991 Aug; 18(4):199-201. PubMed ID: 1937844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation.
    Bick RL; Kovacs I; Fekete LF
    Thromb Res; 1976 Jun; 8(6):745-56. PubMed ID: 60793
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of 3 methods of study of antithrombin III].
    Nakabanda A; Katsadze IuL; Kotovshchikova MA
    Lab Delo; 1984; (5):276-9. PubMed ID: 6204109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.